Follow The Filings

ZURA Zura Bio

Zura Bio earnings company data as of 7:57 PM ET 11/3

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS -0.21 -0.20 Beat
Rev — — —

Insider trades

Open-market buys and sales by ZURA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZURA insider trades
  • $12.5M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. AI Biotechnology LLC 10% owner, +3 joint filers
    Buy
    $12.5M 2,000,000 shares at $6.25 +44% to stake
    Traded Feb 26 Filed Mar 2

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
10-Q
8-K 2.02,7.01,9.01
8-K 7.01,9.01
10-Q
8-K 2.02,7.01,9.01
8-K 7.01,9.01
8-K 5.02,5.07,9.01
8-K 5.02
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
DEF 14A
8-K 5.02,9.01
8-K 2.02,7.01,9.01
10-K
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13D/A —
8-K 1.01,2.02,8.01,9.01
8-K/A 9.01
424B5

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf